Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

The Innate Part of the Adaptive Immune System.

Hillion S, Arleevskaya MI, Blanco P, Bordron A, Brooks WH, Cesbron JY, Kaveri S, Vivier E, Renaudineau Y.

Clin Rev Allergy Immunol. 2019 Jun 1. doi: 10.1007/s12016-019-08740-1. [Epub ahead of print] Review.

PMID:
31154567
2.

Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study.

Raskovalova T, Berger MG, Jacob MC, Park S, Campos L, Aanei CM, Kasprzak J, Pereira B, Labarère J, Cesbron JY, Veyrat-Masson R.

Haematologica. 2019 Dec;104(12):2382-2390. doi: 10.3324/haematol.2018.202275. Epub 2019 Apr 19.

3.

Effects of immunoadsorption combined with membrane filtration on complement markers - results of a randomized, controlled, crossover study.

Defendi F, Malvezzi P, Eskandary F, Cesbron JY, Rostaing L, Böhmig GA, Dumestre-Pérard C.

Transpl Int. 2019 Aug;32(8):876-883. doi: 10.1111/tri.13431. Epub 2019 Apr 5.

PMID:
30901502
4.

Letter to the Editor: Protein phosphatase 1 subunit Ppp1r15a/GADD34 is overexpressed in systemic lupus erythematosus and related to the expression of type I interferon response genes.

Plazy C, Dumestre-Pérard C, Sarrot-Reynauld F, Audoin P, Quesada JL, Pierre P, Bouillet L, Cesbron JY, Clavarino G.

Autoimmun Rev. 2019 Feb;18(2):211-213. doi: 10.1016/j.autrev.2018.09.007. Epub 2018 Dec 19. No abstract available.

PMID:
30578961
5.

Diagnostic biologique des angioedèmes bradykiniques : les recommandations du CREAK.

Bouillet L, Defendi F, Hardy G, Cesbron JY, Boccon-Gibod I, Deroux A, Mansard C, Launay D, Gompel A, Floccard B, Jaussaud R, Beaudouin E, Armengol G, Olliver Y, Gayet S, Du Than A, Sailler L, Guez S, Sarrat A, Sorin L, de Moreuil C, Pelletier F, Javaud N, Marmion N, Fain O, Fauré J, Dumestre-Pérard C.

Presse Med. 2019 Jan;48(1 Pt 1):55-62. doi: 10.1016/j.lpm.2018.06.015. Epub 2018 Nov 8. French.

PMID:
30416009
6.

Accurate quantification of fourteen normal bone marrow cell subsets in infants to the elderly by flow cytometry.

Pont J, Souvignet A, Campos L, Plesa A, Bulabois B, Pernollet M, Raskovalova T, Dumestre-Perard C, Cesbron JY, Jacob MC.

Cytometry B Clin Cytom. 2018 Sep;94(5):627-636. doi: 10.1002/cyto.b.21643.

7.

Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers.

Dumestre-Pérard C, Clavarino G, Colliard S, Cesbron JY, Thielens NM.

Autoimmun Rev. 2018 Sep;17(9):890-899. doi: 10.1016/j.autrev.2018.03.013. Epub 2018 Jul 29. Review.

PMID:
30009962
8.

Routinely used immunoassays do not detect circulating anti-GBM antibodies against native NC1 hexamer and EA epitope of the α3 chain of type IV collagen.

Clavarino G, Gauthier A, Hellmark T, Carron PL, Giovannini D, Colliard S, Dragon-Durey MA, Segelmark M, Cesbron JY, Dumestre-Pérard C.

Eur J Immunol. 2018 Jun;48(6):1082-1084. doi: 10.1002/eji.201747324. Epub 2018 May 2.

9.

Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.

Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, Fougere M, Bardin N, Bouillet L, Cesbron JY, Thielens NM, Dumestre-Pérard C.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1263-1268. doi: 10.1002/acr.23449. Epub 2018 Jun 21.

10.

Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry.

Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, Cesbron JY, Dumestre-Pérard C, Jacob MC.

PLoS One. 2016 Sep 22;11(9):e0162209. doi: 10.1371/journal.pone.0162209. eCollection 2016.

11.

Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus.

Plawecki M, Lheritier E, Clavarino G, Jourde-Chiche N, Ouili S, Paul S, Gout E, Sarrot-Reynauld F, Bardin N, Boëlle PY, Chiche L, Bouillet L, Thielens NM, Cesbron JY, Dumestre-Pérard C.

PLoS One. 2016 Sep 15;11(9):e0160879. doi: 10.1371/journal.pone.0160879. eCollection 2016.

12.

One tube with eight antibodies for 14-part bone marrow leukocyte differential using flow cytometry.

Jacob MC, Souvignet A, Pont J, Solly F, Mondet J, Kesr S, Pernollet M, Dumestre-Perard C, Campos L, Cesbron JY.

Cytometry B Clin Cytom. 2017 Jul;92(4):299-309. doi: 10.1002/cyto.b.21369. Epub 2016 May 6.

13.

Unfolded protein response gene GADD34 is overexpressed in rheumatoid arthritis and related to the presence of circulating anti-citrullinated protein antibodies.

Clavarino G, Adriouach S, Quesada JL, Clay M, Chevreau M, Trocmé C, Grange L, Gaudin P, Gatti E, Pierre P, Cesbron JY, Dumestre-Pérard C.

Autoimmunity. 2016;49(3):172-8. doi: 10.3109/08916934.2016.1138220. Epub 2016 Feb 1.

PMID:
26829377
14.

Ataxia with cerebellar lesions in mice expressing chimeric PrP-Dpl protein.

Lemaire-Vieille C, Bailly Y, Erlich P, Loeuillet C, Brocard J, Haeberlé AM, Bombarde G, Rak C, Demais V, Dumestre-Pérard C, Gagnon J, Cesbron JY.

J Neurosci. 2013 Jan 23;33(4):1391-9. doi: 10.1523/JNEUROSCI.2231-12.2013.

15.

Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate.

Bouillet L, Boccon-Gibod I, Dumestre-Perard C, Cesbron JY, Massot C.

Br J Dermatol. 2011 Jun;164(6):1406-7. doi: 10.1111/j.1365-2133.2011.10316.x. No abstract available.

PMID:
21410680
16.

Prion replication in the hematopoietic compartment is not required for neuroinvasion in scrapie mouse model.

Loeuillet C, Lemaire-Vieille C, Naquet P, Cesbron-Delauw MF, Gagnon J, Cesbron JY.

PLoS One. 2010 Oct 5;5(10). pii: e13166. doi: 10.1371/journal.pone.0013166.

17.

Sex effect in mouse and human prion disease.

Loeuillet C, Boelle PY, Lemaire-Vieille C, Baldazza M, Naquet P, Chambon P, Cesbron-Delauw MF, Valleron AJ, Gagnon J, Cesbron JY.

J Infect Dis. 2010 Aug 15;202(4):648-54. doi: 10.1086/654818.

PMID:
20594106
18.

Complement protein C1q forms a complex with cytotoxic prion protein oligomers.

Erlich P, Dumestre-Pérard C, Ling WL, Lemaire-Vieille C, Schoehn G, Arlaud GJ, Thielens NM, Gagnon J, Cesbron JY.

J Biol Chem. 2010 Jun 18;285(25):19267-76. doi: 10.1074/jbc.M109.071860. Epub 2010 Apr 21.

19.

Type III hereditary angio-oedema: clinical and biological features in a French cohort.

Vitrat-Hincky V, Gompel A, Dumestre-Perard C, Boccon-Gibod I, Drouet C, Cesbron JY, Lunardi J, Massot C, Bouillet L.

Allergy. 2010 Oct;65(10):1331-6. doi: 10.1111/j.1398-9995.2010.02368.x. Epub 2010 Apr 7.

PMID:
20384613
20.

Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin.

Gout E, Garlatti V, Smith DF, Lacroix M, Dumestre-Pérard C, Lunardi T, Martin L, Cesbron JY, Arlaud GJ, Gaboriaud C, Thielens NM.

J Biol Chem. 2010 Feb 26;285(9):6612-22. doi: 10.1074/jbc.M109.065854. Epub 2009 Dec 23.

21.

Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.

Bouillet L, Boccon-Gibod I, Ponard D, Drouet C, Cesbron JY, Dumestre-Perard C, Monnier N, Lunardi J, Massot C, Gompel A.

Ann Allergy Asthma Immunol. 2009 Nov;103(5):448. doi: 10.1016/S1081-1206(10)60369-9. No abstract available.

PMID:
19927548
22.

[Care networks, mobile palliative and supportive teams. What benefits are there for patients, natural caregivers and general practitioners in patient homes?].

Hubault P, Chataigner B, Diquero V, Cesbron JY, Pommateau R, Cotinat JP, Guitard V, Mathien L, Thetas E.

Rev Prat. 2009 Jun 20;59(6):813-9. French.

PMID:
19642437
23.

The effect of metal imbalances on scrapie neurodegeneration.

Hortells P, Monleón E, Acín C, Vargas A, Vasseur V, Salomon A, Ryffel B, Cesbron JY, Badiola JJ, Monzón M.

Zoonoses Public Health. 2010 Aug;57(5):358-66. doi: 10.1111/j.1863-2378.2009.01230.x. Epub 2009 Apr 8.

PMID:
19486493
25.

Aspergillus conidia activate the complement by the mannan-binding lectin C2 bypass mechanism.

Dumestre-Pérard C, Lamy B, Aldebert D, Lemaire-Vieille C, Grillot R, Brion JP, Gagnon J, Cesbron JY.

J Immunol. 2008 Nov 15;181(10):7100-5.

26.

Effect of the dimethoate administration on a Scrapie murine model.

Hortells P, Monleón E, Acín C, Vargas A, Ryffel B, Cesbron JY, Badiola JJ, Monzón M.

Zoonoses Public Health. 2008 Sep;55(7):368-75. doi: 10.1111/j.1863-2378.2008.01139.x.

PMID:
18667030
27.
28.

PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.

Erlich P, Cesbron JY, Lemaire-Vieille C, Curt A, Andrieu JP, Schoehn G, Jamin M, Gagnon J.

Biochem Biophys Res Commun. 2008 Jan 18;365(3):478-83. Epub 2007 Nov 13.

PMID:
17997980
29.

Activation of classical pathway of complement cascade by soluble oligomers of prion.

Dumestre-Pérard C, Osmundson J, Lemaire-Vieille C, Thielens N, Grives A, Favier B, Csopaki F, Jamin M, Gagnon J, Cesbron JY.

Cell Microbiol. 2007 Dec;9(12):2870-9.

PMID:
17991046
30.

Can a second wave of new variant of the CJD be discarded in absence of observation of clinical non Met-Met cases?

Valleron AJ, Boelle PY, Chatignoux E, Cesbron JY.

Rev Epidemiol Sante Publique. 2006 Apr;54(2):111-5.

PMID:
16830965
31.

Overexpression of cellular prion protein induces an antioxidant environment altering T cell development in the thymus.

Jouvin-Marche E, Attuil-Audenis V, Aude-Garcia C, Rachidi W, Zabel M, Podevin-Dimster V, Siret C, Huber C, Martinic M, Riondel J, Villiers CL, Favier A, Naquet P, Cesbron JY, Marche PN.

J Immunol. 2006 Mar 15;176(6):3490-7.

32.

Epidemiological evidence of higher susceptibility to vCJD in the young.

Boëlle PY, Cesbron JY, Valleron AJ.

BMC Infect Dis. 2004 Aug 10;4:26.

33.

Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain.

Bailly Y, Haeberlé AM, Blanquet-Grossard F, Chasserot-Golaz S, Grant N, Schulze T, Bombarde G, Grassi J, Cesbron JY, Lemaire-Vieille C.

J Comp Neurol. 2004 May 24;473(2):244-69.

PMID:
15101092
34.

Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis.

Boëlle PY, Thomas G, Valleron AJ, Cesbron JY, Will R.

Stat Methods Med Res. 2003 Jun;12(3):221-33.

PMID:
12828243
35.

PrP expression and replication by Schwann cells: implications in prion spreading.

Follet J, Lemaire-Vieille C, Blanquet-Grossard F, Podevin-Dimster V, Lehmann S, Chauvin JP, Decavel JP, Varea R, Grassi J, Fontès M, Cesbron JY.

J Virol. 2002 Mar;76(5):2434-9.

36.

Human FDC express PrPc in vivo and in vitro.

Thielen C, Antoine N, Mélot F, Cesbron JY, Heinen E, Tsunoda R.

Dev Immunol. 2001;8(3-4):259-66.

37.

Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom.

Valleron AJ, Boelle PY, Will R, Cesbron JY.

Science. 2001 Nov 23;294(5547):1726-8.

38.

Differential expression of cellular prion protein on human blood and tonsil lymphocytes.

Antoine N, Cesbron JY, Coumans B, Jolois O, Zorzi W, Heinen E.

Haematologica. 2000 May;85(5):475-80.

39.

Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice.

Lemaire-Vieille C, Schulze T, Podevin-Dimster V, Follet J, Bailly Y, Blanquet-Grossard F, Decavel JP, Heinen E, Cesbron JY.

Proc Natl Acad Sci U S A. 2000 May 9;97(10):5422-7.

40.

Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease.

Blanquet-Grossard F, Sazdovitch V, Jean A, Deslys JP, Dormont D, Hauw JJ, Marion D, Brown P, Cesbron JY.

J Dent Res. 2000 Feb;79(2):700. No abstract available.

PMID:
10728969
41.

Cost-effectiveness of bovine spongiform encephalopathy screening.

Cohen CH, Cesbron JY, Valleron AJ.

Vet Rec. 1999 Jun 19;144(25):703-6. No abstract available.

PMID:
10420486
42.

Dermal endothelial cells and keratinocytes produce IL-7 in vivo after human Schistosoma mansoni percutaneous infection.

Roye O, Delhem N, Trottein F, Remoué F, Nutten S, Decavel JP, Delacre M, Martinot V, Cesbron JY, Auriault C, Wolowczuk I.

J Immunol. 1998 Oct 15;161(8):4161-8.

43.

Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin.

Delhem N, Hadida F, Gorochov G, Carpentier F, de Cavel JP, Andréani JF, Autran B, Cesbron JY.

J Immunol. 1998 Aug 15;161(4):2060-9.

44.

Allergen-induced migration of human cells in allergic severe combined immunodeficiency mice.

Duez C, Akoum H, Marquillies P, Cesbron JY, Tonnel AB, Pestel J.

Scand J Immunol. 1998 Feb;47(2):110-5.

45.

Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection.

Faisst S, Guittard D, Benner A, Cesbron JY, Schlehofer JR, Rommelaere J, Dupressoir T.

Int J Cancer. 1998 Feb 9;75(4):584-9.

46.

The SCID mouse mutant: definition and potential use as a model for immune and hematological disorders.

Leblond V, Autran B, Cesbron JY.

Hematol Cell Ther. 1997 Oct;39(5):213-21. Review.

PMID:
9395894
47.

Expression of a Schistosoma mansoni 28-kilodalton glutathione S-transferase in the livers of transgenic mice and its effect on parasite infection.

Xu X, Lemaire C, Grzych JM, Pierce RJ, Raccurt M, Mullier F, Zerimech F, Decavel JP, Peyrol S, Liu J, Fontaine J, Lafitte S, Capron A, Cesbron JY.

Infect Immun. 1997 Sep;65(9):3867-74. Erratum in: Infect Immun 1998 Mar;66(3):1276.

48.

Anticardiolipin antibodies and physical disability in the elderly.

Cesbron JY, Amouyel P, Masy E.

Ann Intern Med. 1997 Jun 15;126(12):1003. No abstract available.

PMID:
9182462
49.

Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a case-control study.

Bouillanne O, Millaire A, de Groote P, Puisieux F, Cesbron JY, Jude B, Hatron PY, Ducloux G.

Am Heart J. 1996 Oct;132(4):790-5.

PMID:
8831368
50.

Thymocyte and thymic microenvironment alterations during a systemic HIV infection in a severe combined immunodeficient mouse model.

Autran B, Guiet P, Raphael M, Grandadam M, Agut H, Candotti D, Grenot P, Puech F, Debre P, Cesbron JY.

AIDS. 1996 Jun;10(7):717-27.

PMID:
8805862

Supplemental Content

Loading ...
Support Center